Stay updated on RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page.

Latest updates to the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.3 was added to the Record History. The HHS Vulnerability Disclosure item and the Revision: v3.3.2 entry were removed.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision history now includes a new entry for v3.3.2 and removes the v3.2.0 entry.SummaryDifference0.1%

- Check40 days agoChange DetectedThe banner about government funding delays and potential data being out of date was removed.SummaryDifference0.8%

- Check55 days agoChange DetectedThe new screenshot shows only a visual redesign of the Record History page (header layout and styling), with no changes to the version entries or underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedSummary: The page now announces a government funding lapse with current operating status guidance and upgrades the version from v3.1.0 to v3.2.0.SummaryDifference13%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page.